This may be just what some people kneed. Joint issues have never been limited to the elderly, as more young people deal with ...

A new class of medicines offers steadier protection with fewer injections, while gene therapy is beginning to test the promise of a one-time treatment.

Baltimore officials pledge zero tolerance for illegal cannabis sales, after Sun investigation ...

For the final 10% of cystic fibrosis patients who cannot benefit from breakthrough drugs, Emily's Entourage is funding ...

Potentially accelerates development, assessment, and review for approval by FDA Sepsis impacts about 1.7 million U.S. adults ...

Some of the most leading-edge medical breakthroughs are moving faster than the health care system can absorb, panelist after panelist said at the Aspen Ideas: Health conference this week. Why it ...

Medicine is entering a new era of breakthrough science, with innovations once considered out of reach now becoming reality. Researchers are developing therapies that target diseases in entirely new ...

From artificial intelligence (AI) tools entering everyday NHS care to breakthroughs in cancer, rare disease and emergency response, 2025 delivered a series of advances that signalled meaningful change ...

The past 12 months recorded several medical breakthroughs, including first-time gene therapy outcomes, notable FDA approvals and virtual healthcare delivery, ABC News reported Dec. 30. Here are seven ...

Innovation in life sciences is accelerating, but so are the risks and complexities surrounding it. The companies that succeed will be those that can identify critical dependencies, build resilience ...

A new experimental drug for pancreatic cancer, daraxonrasib, appears to have extended the lives of some patients with advanced disease by several months, according to clinical trial results out last ...

ALPS Medical Breakthroughs ETF (SBIO) targets late-stage clinical biotech firms poised for FDA approval or acquisition, offering high-risk, high-reward exposure. SBIO surged 91% over the past year, ...